ORDER A TEST
CLIENT LOGIN

Reclassification of Early Stage Breast Cancer Into Treatment Groups by Combining the Use of Immunohistochemistry and Microarray Analysis

PUBLICATION: Vol 115 No 3/4 (2019): South African Journal of Read More

2024-03-25T08:56:28-07:00March 27th, 2019|BluePrint, Evidence, Other, Validation|

Copy Number Profiling of MammaPrint Genes Reveals Association with the Prognosis of Breast Cancer Patients

PUBLICATION: J Breast Cancer. 2017 Sep;20(3):246-253. English. Published online Sep Read More

2024-03-25T09:00:19-07:00September 22nd, 2017|BluePrint, Evidence, MammaPrint, Other, Validation|

Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients

PUBLICATION: Ann Surg Oncol. 2012 Oct;19(10):3257-63. doi: 10.1245/s10434-012-2561-6. Epub 2012 Read More

2024-03-25T10:51:59-07:00August 15th, 2012|BluePrint, Evidence, Other, Validation|

Gene Expression Profiles from Formalin Fixed Paraffin Embedded Breast Cancer Tissue are Largely Comparable to Fresh Frozen Matched Tissue

PUBLICATION: PLoS One. 2011 Feb 11;6(2):e17163. doi: 10.1371/journal.pone.0017163. AUTHORS: Mittempergher Read More

2024-03-07T11:49:23-08:00February 11th, 2011|Evidence, MammaPrint, Other, Validation|

Biological Functions of the Genes in the MammaPrint® Breast Cancer Profile Reflect the Hallmarks of Cancer

PUBLICATION: Biomarker Insights. 2010 Nov 28;5:129-38. doi: 10.4137/BMI.S6184. AUTHORS: Tian Read More

2024-03-25T10:58:58-07:00November 24th, 2010|Evidence, MammaPrint, Other, Validation|
Go to Top